E1A can provoke G1 exit that is refractory to p21 and independent of activating Cdk2

Circulation Research

Volumn 85, Issue 4, 1999, Pages 319-328

  Akli, Saïd ^a   Zhan, Song ^a   Abdellatif, Maha ^a   Schneider, Michael D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Cell cycle; Cyclin dependent kinase; E1A; P21

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN E; PROTEIN P16; PROTEIN P21; TRANSCRIPTION FACTOR E2F; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE G1 PHASE; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSFER; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT;

EID: 0033587998     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.4.319     Document Type: Article

References (71)

1. Claycomb WC, Di Nardo P, eds. Cardiac Growth and Regeneration. New York, NY: New York Academy of Sciences; 1995.
2. MacLellan WR, Schneider MD. The cardiac cell cycle. In: Harvey R, Rosenthal N, eds. Cardiac Development. San Diego, Calif: Academic Press; 1998:405-427.
3. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998;83:1-14.
4. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998;83:15-26.
5. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A. 1998;95:8801-8805.
6. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
7. Hunter T. Oncoprotein networks. Cell. 1997;88:333-346.
8. Knudsen ES, Buckmaster C, Chen TT, Feramisco JR, Wang JYJ. Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev. 1998;12:2278-2292.
9. Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol. 1998;18:753-761.
10. Adams PD, Li X, Sellers WR, Baker KB, Leng X, Harper JW, Taya Y, Kaelin WG Jr. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol Cell Biol. 1999;19:1068-1080.
11. Peeper DS, Parker LL, Ewen ME, Toebes M, Hall FL, Xu M, Zantema A, van der Eb AJ, Piwnica-Worms H. A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J. 1993; 12:1947-1954.
12. Xiao ZX, Ginsberg D, Ewen M, Livingston DM. Regulation of the retinoblastoma protein-related protein p107 by G(1) cyclin-associated kinases. Proc Natl Acad Sci U S A. 1996;93:4633-4637.
13. 1 cyclin-dependent kinase activity. Genes Dev. 1995;9:2873-2887.
14. Hofmann F, Livingston DM. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev. 1996;10: 851-861.
15. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991;67: 1169-1179.
16. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992;11: 961-971.
17. Resnitzky D, Hengst L, Reed SI. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G(1) by p27(Kip1). Mol Cell Biol. 1995;15:4347-4352.
18. Cai K, Dynlacht BD. Activity and nature of p21(WAF1) complexes during the cell cycle. Proc Natl Acad Sci U S A. 1998;95:12254-12259.
19. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995;267:1018-1021.
20. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994;211:90-98.
21. Fromm L, Overbeek PA. Regulation of cyclin and cyclin-dependent kinase gene expression during lens differentiation requires the retinoblastoma protein. Oncogene. 1996;12:69-75.
22. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999; 19:2109-2117.
23. Brooks G, Poolman RA, McGill CJ, Li JM. Expression and activities of cyclins and cyclin dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol. 1997;29:2261-2271.
24. Poolman RA, Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J Mol Cell Cardiol. 1998;30:2121-2135.
25. Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol. 1998;30:563-578.
26. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem. 1995;270:7791-7794.
27. Kirshenbaum LA, Abdellatif M, Chakraborty S, Schneider MD. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol. 1996;179:402-411.
28. Agah R, Kirshenbaum LA, Truong LD, Chakraborty S, Abdellatif M, Michael LH, Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle re-entry and p53-independent apoptosis in post-mitotic adult myocardium in vivo. J Clin Invest. 1997;100:2722-2728.
29. Liu Y, Kitsis RN. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J Cell Biol. 1996;133:325-334.
30. Bishopric NH, Zeng GQ, Sato B, Webster KA. Adenovirus E1A inhibits cardiac myocyte-specific gene expression through its amino terminus. J Biol Chem. 1997;272:20584-20594.
31. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95:2979-2984.
32. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697-705.
33. Sekiguchi T, Hunter T. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHKZ1 cells. Oncogene. 1998;16:369-380.
34. Dimri GP, Nakanishi M, Desprez PY, Smith JR, Campisi J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol. 1996;16:2987-2997.
35. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A. 1997;94:7245-7250.
36. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 1998;12:2120-2130.
37. Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A. 1997;94:11268-11273.
38. Paradis P, Maclellan WR, Belaguli NS, Schwanz RJ, Schneider MD. Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes. J Biol Chem. 1996;271: 10827-10833.
39. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature. 1997;387:422-426.
40. Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med. 1995;1:1052-1056.
41. Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M. Adenovirally transferred p16(INK4/CDKN2) and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med. 1997;3:313-319.
42. Cress WD, Johnson DG, Nevins JR. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus-E4. Mol Cell Biol. 1993;13:6314-6325.
43. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA. 1994;91:8802-8806.
44. van den Heuvel S, Harlow E. Distinct role for cyclin-dependent kinases in cell cycle control. Science. 1993;262:2050-2054.
45. Wang H-GH, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B, Moran E. Identification of specific adenovirus-E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol. 1993;67:476-488.
46. Zhao JY, Dynlacht B, Imai T, Hori T, Harlow E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 1998;12:456-461.
47. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation. 1998;98:1329-1334.
48. Qin XQ, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin WG. The transcription factor E2F-1 is a downstream target of Rb action. Mol Cell Biol. 1995;15:742-755.
49. Mann DJ, Jones NC. E2F-1 but not E2F-4 can overcome p16-induced g1 cell-cycle arrest. Curr Biol. 1996;6:474-483.
50. Alevizopoulos K, Vlach J, Hennecke S, Amati B. Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) and of hypophosphorylated retinoblastoma family proteins. EMBO J. 1997;16: 5322-5333.
51. Leng XH, Connell-Crowley L, Goodrich D, Harper JW. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblasloma protein phosphorylation. Curr Biol. 1997;7:709-712.
52. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 1997;11:1479-1492.
53. Perkins ND, Felzien LK, Betts JC, Leung KY, Beach DH, Nabel GJ. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science. 1997;275:523-527.
54. Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D, Harel-Bellan A. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature. 1998;396: 184-186.
55. Dieckmann A, Krippl B. The E1A transcriptional control region is efficiently activated in proliferating tissues of transgenic mice. Oncogene. 1994;9:2227-2233.
56. Ogryzko VV, Wong P, Howard BH. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol. 1997; 17:4877-4882.
57. Hua XH, Yan H, Newport J. A role for cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle. J Cell Biol. 1997;137:183-192.
58. Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell. 1997;8:287-301.
59. Keblusek P, Dorsman JC, Teunisse AF, Teunissen H, van der Eb AJ, Zantema A. The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1). J Gen Virol. 1999;80:381-390.
60. Jiang W, Hunter T. Identification and characterization of a human protein kinase related to budding yeast Cdc7p. Proc Natl Acad Sci U S A. 1997; 94:14320-14325.
61. Voitenleitner C, Fanning E, Nasheuer HP. Phosphorylation of DNA polymerase α-primase by cyclin A-dependent kinases regulates initiation of DNA replication in vitro. Oncogene. 1997;14:1611-1615.
62. Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 1999;18:396-410.
63. Alevizopoulos K, Catarin B, Vlach J, Amati B. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1). EMBO J. 1998;17:5987-5997.
64. Howe JA, Bayley ST. Effects of AdS E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology. 1992;186:15-24.
65. Jelsma TN, Howe JA, Evelegh CM, Cunniff NF, Skiadopoulos MH, Floroff MR, Denman JE, Bayley ST. Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activation. Virology. 1988;163: 494-502.
66. Barbeau D, Charbonneau R, Whalen SG, Bayley ST, Branton PE. Functional interactions within adenovirus E1A protein complexes. Oncogene. 1994;9:359-373.
67. Taylor DA, Kraus VB, Schwarz JJ, Olson EN, Kraus WE. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol Cell Biol. 1993;13: 4714-4727.
68. Kraus VB, Inostroza JA, Yeung K, Reinberg D, Nevins JR. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proc Natl Acad Sci U S A. 1994;91:6279-6282.
69. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch S, Thimmapaya B. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci USA. 1996;93:3088-3093.
70. Sang NL, Giordano A. Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins. J Cell Physiol. 1997;170:182-191.
71. French BA, Mazur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 1994;90:2402-2413.